chem_id	chebi_id	cas_registry	frac_id(FK)	frac_id	frac_code	moa_code	moa_name	target_code	target_site	group_name	chemical_group	common_name	resistance_risk	comments
1	CHEBI:3009	71626-11-4	1	1	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2	CHEBI:82779	98243-83-5	2	2	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3	CHEBI:5194	57646-30-7	3	3	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
4	CHEBI:6790	57837-19-1	4	4	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
5	CHEBI:60607	70630-17-0	5	5	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
6	CHEBI:81937	77732-09-3	6	6	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
7	CHEBI:81969	58810-48-3	7	7	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
8	CHEBI:81952	41483-43-6	8	8	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
9	CHEBI:81958	5221-53-4	9	9	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
10	CHEBI:81989	23947-60-6	10	10	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
11	CHEBI:5827	10004-44-1	11	11	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
12	CHEBI:81936	26530-20-1	12	12	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
13	CHEBI:138856	14698-29-4	13	13	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
14	CHEBI:3015	17804-35-2	14	systemic	14	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
15	CHEBI:3392	10605-21-7	15	systemic	15	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
16	CHEBI:81926	3878-19-1	16	16	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
17	CHEBI:45979	148-79-8	17	17	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
18	CHEBI:82060	23564-06-9	18	18	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
19	CHEBI:35014	23564-05-8	19	systemic	19	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
20	CHEBI:4520	87130-20-9	20	systemic	20	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
21	CHEBI:82048	156052-68-5	21	21	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
22	CHEBI:82856	162650-77-3	22	22	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
23	CHEBI:7957	66063-05-6	23	23	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
24	CHEBI:81764	239110-15-7	24	24	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
25	CHEBI:82860	130339-07-0	25	25	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
26	CHEBI:38628	129558-76-5	26	26	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
27	CHEBI:82052	15310-01-7	27	27	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
28	CHEBI:81792	66332-96-5	28	28	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
29	CHEBI:81823	55814-41-0	29	29	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
30	CHEBI:83065	875915-78-9	30	30	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
31	CHEBI:83070	658066-35-4	31	31	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
32	CHEBI:81994	24691-80-3	32	32	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
33	CHEBI:3405	5234-68-4	33	systemic	33	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
34	CHEBI:7858	5259-88-1	34	34	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
35	CHEBI:81794	130000-40-7	35	35	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
36	CHEBI:83092	1072957-71-1	36	36	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
37	CHEBI:83106	581809-46-3	37	37	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
38	CHEBI:83113	907204-31-3	38	38	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
39	CHEBI:81793	123572-88-3	39	39	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
40	CHEBI:83126	881685-58-1	40	40	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
41	CHEBI:83134	494793-67-8	41	41	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
42	CHEBI:81777	183675-82-3	42	42	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
43	CHEBI:83173	874967-67-6	43	43	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
44	CHEBI:81822	188425-85-6	44	44	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
45	CHEBI:40909	131860-33-8	45	preventive, curative, and systemic	45	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
46	CHEBI:83185	850881-70-8	46	46	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
47	CHEBI:83187	238410-11-2	47	47	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
48	CHEBI:83194	918162-02-4	48	48	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
49	CHEBI:83197	117428-22-5	49	49	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
50	CHEBI:83202	862588-11-2	50	50	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
51	CHEBI:83205	173662-97-0	51	51	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
52	CHEBI:78780	175013-18-0	52	52	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
53	CHEBI:83212	915410-70-7	53	53	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
54	CHEBI:83213	902760-40-1	54	54	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
55	CHEBI:2962	143390-89-0	55	55	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
56	CHEBI:81833	141517-21-7	56	56	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
57	CHEBI:83218	149961-52-4	57	57	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
58	CHEBI:83220	366815-39-6	58	58	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
59	CHEBI:81831	133408-50-1	59	59	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
60	CHEBI:81832	248593-16-0	60	60	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
61	CHEBI:59340	131807-57-3	61	61	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
62	CHEBI:83253	361377-29-9	62	62	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
63	CHEBI:83258	161326-34-7	63	63	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
64	CHEBI:83261	799247-52-2	64	64	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
65	CHEBI:81841	120116-88-3	65	65	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
66	CHEBI:81846	348635-87-0	66	66	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
67	CHEBI:82153	485-31-4	67	67	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
68	CHEBI:83372	131-72-6	68	68	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
69	CHEBI:83379	39300-45-3	69	69	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
70	CHEBI:81843	79622-59-6	70	70	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
71	CHEBI:81844	89269-64-7	71	71	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
72	CHEBI:81918	900-95-8	72	72	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
73	CHEBI:35036	639-58-7	73	73	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
74	CHEBI:30473	76-87-9	74	74	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
75	CHEBI:83393	175217-20-6	75	75	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
76	CHEBI:83398	865318-97-4	76	76	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
77	CHEBI:4045	121552-61-2	77	77	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
78	CHEBI:6751	110235-47-7	78	78	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
79	CHEBI:8674	53112-28-0	79	79	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
80	CHEBI:15353	2079-00-7	80	80	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
81	CHEBI:81419	6980-18-3	81	81	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
82	CHEBI:17076	57-92-1	82	82	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
83	CHEBI:27701	79-57-2	83	83	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
84	CHEBI:82040	124495-18-7	84	84	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
85	CHEBI:83555	189278-12-4	85	85	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
86	CHEBI:34759	74738-17-3	86	86	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
87	CHEBI:81763	131341-86-1	87	87	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
88	CHEBI:3656	84332-86-5	88	88	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
89	CHEBI:28909	36734-19-7	89	preventive, early curative, and systemic	89	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
90	CHEBI:8450	32809-16-8	90	90	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
91	CHEBI:9986	50471-44-8	91	91	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
92	92	92	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
93	CHEBI:34735	17109-49-8	93	93	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
94	CHEBI:79737	26087-47-8	94	94	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
95	CHEBI:81942	13457-18-6	95	95	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
96	CHEBI:6047	50512-35-1	96	96	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
97	CHEBI:17097	92-52-4	97	97	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
98	CHEBI:3628	2675-77-6	98	98	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
99	CHEBI:27864	99-30-9	99	99	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
100	CHEBI:34908	82-68-8	100	100	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
101	CHEBI:82044	117-18-0	101	101	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
102	CHEBI:81731	57018-04-9	102	102	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
103	CHEBI:81761	2593-15-9	103	103	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
104	CHEBI:83279	55406-53-6	104	104	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
105	CHEBI:82033	24579-73-5	105	105	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
106	CHEBI:82084	19622-08-3	106	106	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
107	107	107	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
108	108	108	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
109	109	109	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
110	110	110	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
111	111	111	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
112	CHEBI:83629	112	112	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
113	CHEBI:9715	26644-46-2	113	113	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
114	CHEBI:81972	88283-41-4	114	114	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
115	CHEBI:83823	847749-37-5	115	115	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
116	CHEBI:4998	60168-88-9	116	116	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
117	CHEBI:7645	63284-71-9	117	117	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
118	CHEBI:81927	35554-44-0	118	118	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
119	CHEBI:83832	134074-64-9	119	119	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
120	CHEBI:81775	101903-30-4	120	120	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
121	CHEBI:8434	67747-09-5	121	121	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
122	CHEBI:81784	68694-11-1	122	122	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
123	CHEBI:81898	60207-31-0	123	123	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
124	CHEBI:3130	55179-31-2	124	124	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
125	CHEBI:81900	116255-48-2	125	125	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
126	CHEBI:81758	94361-06-5	126	curative and systemic	126	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
127	CHEBI:81760	119446-68-3	127	127	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
128	CHEBI:81913	83657-18-5	128	128	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
129	CHEBI:4811	133855-98-8	129	129	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
130	CHEBI:4874	60207-93-4	130	130	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
131	CHEBI:81762	114369-43-6	131	131	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
132	CHEBI:83923	136426-54-5	132	132	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
133	CHEBI:81922	85509-19-9	133	133	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
134	CHEBI:81923	76674-21-0	134	134	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
135	CHEBI:81766	79983-71-4	135	135	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
136	CHEBI:81767	86598-92-7	136	136	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
137	CHEBI:81770	125225-28-7	137	137	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
138	CHEBI:81773	125116-23-6	138	138	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
139	CHEBI:75281	88671-89-0	139	139	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
140	CHEBI:81970	66246-88-6	140	140	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
141	CHEBI:8489	60207-90-1	141	141	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
142	CHEBI:81819	149508-90-7	142	142	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
143	CHEBI:81781	107534-96-3	143	143	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
144	CHEBI:81782	112281-77-3	144	144	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
145	CHEBI:9665	43121-43-3	145	145	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
146	CHEBI:9666	55219-65-3	146	146	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
147	CHEBI:81980	131983-72-7	147	147	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
148	CHEBI:82036	178928-70-6	148	148	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
149	CHEBI:83295	91315-15-0	149	systemic	149	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
150	CHEBI:81960	1593-77-7	150	systemic	150	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
151	CHEBI:50145	67564-91-4	151	systemic	151	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
152	CHEBI:9700	81412-43-3	152	systemic	152	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
153	CHEBI:81917	67306-00-7	153	systemic	153	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
154	CHEBI:83283	3478-94-2	154	154	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
155	CHEBI:9242	118134-30-8	155	systemic	155	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
156	CHEBI:81853	126833-17-8	156	locally systemic	156	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
157	CHEBI:83327	473798-59-3	157	157	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
158	CHEBI:81736	88678-67-5	158	systemic	158	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
159	CHEBI:7451	65472-88-0	159	various	159	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
160	CHEBI:9448	91161-71-6	160	various	160	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
161	CHEBI:29703	37248-47-8	161	161	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
162	CHEBI:26194	11113-80-7	162	162	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
163	CHEBI:81848	110488-70-5	163	163	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
164	CHEBI:83428	211867-47-9	164	164	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
165	CHEBI:83663	868390-90-3	165	165	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
166	CHEBI:83601	413615-35-7	166	166	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
167	CHEBI:82023	140923-17-7	167	167	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
168	CHEBI:83610	283159-90-0	168	168	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
169	CHEBI:81802	374726-62-2	169	169	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
170	CHEBI:47617	27355-22-2	170	170	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
171	CHEBI:45141	57369-32-1	171	171	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
172	CHEBI:81783	41814-78-2	172	172	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
173	CHEBI:3434	104030-54-8	173	173	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
174	CHEBI:3434	139920-32-4	174	174	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
175	CHEBI:3434	115852-48-7	175	175	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
176	CHEBI:3434	135158-54-2	176	176	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
177	CHEBI:3434	27605-76-1	177	177	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
178	CHEBI:81825	223580-51-6	178	178	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
179	CHEBI:83657	224049-04-1	179	179	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
180	CHEBI:6364	9008-22-4	180	180	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
181	CHEBI:6364	181	181	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
182	CHEBI:81788	57966-95-7	182	182	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
183	CHEBI:84033	39148-24-8	183	183	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
184	CHEBI:44976	13598-36-2	184	184	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
185	CHEBI:83341	76280-91-6	185	185	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
186	CHEBI:83335	72459-58-6	186	186	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
187	CHEBI:81801	106917-52-6	187	187	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
188	CHEBI:81759	62865-36-5	188	188	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
189	CHEBI:81933	66952-49-6	189	189	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
190	CHEBI:81797	180409-60-3	190	190	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
191	CHEBI:83345	220899-03-6	191	191	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
192	CHEBI:83346	688046-61-9	192	192	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
193	CHEBI:74889	2439-10-3	193	193	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
194	CHEBI:83277	958647-10-4	194	194	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
195	CHEBI:81844	89269-64-7	195	195	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
196	CHEBI:83268	1003318-67-9	196	196	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
197	CHEBI:83266	376645-78-2	197	197	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
198	198	198	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
199	7440-50-8	199	199	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
200	CHEBI:17909	7704-34-9	200	200	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
201	CHEBI:5015	14484-64-1	201	201	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
202	CHEBI:52492	8018-01-7	202	202	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
203	CHEBI:52497	12427-38-2	203	203	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
204	CHEBI:81539	9006-42-2	204	204	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
205	CHEBI:81755	12071-83-9	205	205	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
206	CHEBI:9495	137-26-8	206	206	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
207	CHEBI:52498	12122-67-7	207	207	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
208	CHEBI:79736	137-30-4	208	208	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
209	CHEBI:34608	133-06-2	209	209	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
210	CHEBI:81938	2425-06-1	210	210	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
211	CHEBI:82019	133-07-3	211	211	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
212	CHEBI:3639	1897-45-6	212	212	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
213	CHEBI:74875	1085-98-9	213	213	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
214	CHEBI:75182	731-27-1	214	214	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
215	CHEBI:82843	108173-90-6	215	215	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
216	CHEBI:5569	13516-27-3	216	216	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
217	CHEBI:82076	101-05-3	217	217	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
218	CHEBI:81842	3347-22-6	218	218	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
219	CHEBI:34620	2439-01-2	219	219	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
220	CHEBI:81826	41205-21-4	220	220	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
865	CHEBI:3009	71626-11-4	221	221	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
866	CHEBI:82779	98243-83-5	222	222	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
867	CHEBI:5194	57646-30-7	223	223	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
868	CHEBI:6790	57837-19-1	224	224	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
869	CHEBI:60607	70630-17-0	225	225	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
870	CHEBI:81937	77732-09-3	226	226	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
871	CHEBI:81969	58810-48-3	227	227	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
872	CHEBI:81952	41483-43-6	228	228	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
873	CHEBI:81958	5221-53-4	229	229	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
874	CHEBI:81989	23947-60-6	230	230	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
875	CHEBI:5827	10004-44-1	231	231	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
876	CHEBI:81936	26530-20-1	232	232	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
877	CHEBI:138856	14698-29-4	233	233	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
878	CHEBI:3015	17804-35-2	234	systemic	234	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
879	CHEBI:3392	10605-21-7	235	systemic	235	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
880	CHEBI:81926	3878-19-1	236	236	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
881	CHEBI:45979	148-79-8	237	237	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
882	CHEBI:82060	23564-06-9	238	238	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
883	CHEBI:35014	23564-05-8	239	systemic	239	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
884	CHEBI:4520	87130-20-9	240	systemic	240	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
885	CHEBI:82048	156052-68-5	241	241	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
886	CHEBI:82856	162650-77-3	242	242	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
887	CHEBI:7957	66063-05-6	243	243	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
888	CHEBI:81764	239110-15-7	244	244	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
889	CHEBI:82860	130339-07-0	245	245	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
890	CHEBI:38628	129558-76-5	246	246	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
891	CHEBI:82052	15310-01-7	247	247	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
892	CHEBI:81792	66332-96-5	248	248	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
893	CHEBI:81823	55814-41-0	249	249	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
894	CHEBI:83065	875915-78-9	250	250	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
895	CHEBI:83070	658066-35-4	251	251	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
896	CHEBI:81994	24691-80-3	252	252	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
897	CHEBI:3405	5234-68-4	253	systemic	253	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
898	CHEBI:7858	5259-88-1	254	254	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
899	CHEBI:81794	130000-40-7	255	255	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
900	CHEBI:83092	1072957-71-1	256	256	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
901	CHEBI:83106	581809-46-3	257	257	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
902	CHEBI:83113	907204-31-3	258	258	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
903	CHEBI:81793	123572-88-3	259	259	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
904	CHEBI:83126	881685-58-1	260	260	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
905	CHEBI:83134	494793-67-8	261	261	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
906	CHEBI:81777	183675-82-3	262	262	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
907	CHEBI:83173	874967-67-6	263	263	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
908	CHEBI:81822	188425-85-6	264	264	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
909	CHEBI:40909	131860-33-8	265	preventive, curative, and systemic	265	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
910	CHEBI:83185	850881-70-8	266	266	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
911	CHEBI:83187	238410-11-2	267	267	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
912	CHEBI:83194	918162-02-4	268	268	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
913	CHEBI:83197	117428-22-5	269	269	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
914	CHEBI:83202	862588-11-2	270	270	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
915	CHEBI:83205	173662-97-0	271	271	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
916	CHEBI:78780	175013-18-0	272	272	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
917	CHEBI:83212	915410-70-7	273	273	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
918	CHEBI:83213	902760-40-1	274	274	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
919	CHEBI:2962	143390-89-0	275	275	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
920	CHEBI:81833	141517-21-7	276	276	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
921	CHEBI:83218	149961-52-4	277	277	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
922	CHEBI:83220	366815-39-6	278	278	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
923	CHEBI:81831	133408-50-1	279	279	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
924	CHEBI:81832	248593-16-0	280	280	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
925	CHEBI:59340	131807-57-3	281	281	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
926	CHEBI:83253	361377-29-9	282	282	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
927	CHEBI:83258	161326-34-7	283	283	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
928	CHEBI:83261	799247-52-2	284	284	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
929	CHEBI:81841	120116-88-3	285	285	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
930	CHEBI:81846	348635-87-0	286	286	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
931	CHEBI:82153	485-31-4	287	287	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
932	CHEBI:83372	131-72-6	288	288	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
933	CHEBI:83379	39300-45-3	289	289	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
934	CHEBI:81843	79622-59-6	290	290	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
935	CHEBI:81844	89269-64-7	291	291	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
936	CHEBI:81918	900-95-8	292	292	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
937	CHEBI:35036	639-58-7	293	293	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
938	CHEBI:30473	76-87-9	294	294	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
939	CHEBI:83393	175217-20-6	295	295	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
940	CHEBI:83398	865318-97-4	296	296	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
941	CHEBI:4045	121552-61-2	297	297	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
942	CHEBI:6751	110235-47-7	298	298	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
943	CHEBI:8674	53112-28-0	299	299	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
944	CHEBI:15353	2079-00-7	300	300	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
945	CHEBI:81419	6980-18-3	301	301	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
946	CHEBI:17076	57-92-1	302	302	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
947	CHEBI:27701	79-57-2	303	303	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
948	CHEBI:82040	124495-18-7	304	304	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
949	CHEBI:83555	189278-12-4	305	305	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
950	CHEBI:34759	74738-17-3	306	306	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
951	CHEBI:81763	131341-86-1	307	307	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
952	CHEBI:3656	84332-86-5	308	308	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
953	CHEBI:28909	36734-19-7	309	preventive, early curative, and systemic	309	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
954	CHEBI:8450	32809-16-8	310	310	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
955	CHEBI:9986	50471-44-8	311	311	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
956	312	312	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
957	CHEBI:34735	17109-49-8	313	313	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
958	CHEBI:79737	26087-47-8	314	314	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
959	CHEBI:81942	13457-18-6	315	315	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
960	CHEBI:6047	50512-35-1	316	316	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
961	CHEBI:17097	92-52-4	317	317	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
962	CHEBI:3628	2675-77-6	318	318	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
963	CHEBI:27864	99-30-9	319	319	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
964	CHEBI:34908	82-68-8	320	320	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
965	CHEBI:82044	117-18-0	321	321	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
966	CHEBI:81731	57018-04-9	322	322	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
967	CHEBI:81761	2593-15-9	323	323	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
968	CHEBI:83279	55406-53-6	324	324	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
969	CHEBI:82033	24579-73-5	325	325	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
970	CHEBI:82084	19622-08-3	326	326	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
971	327	327	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
972	328	328	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
973	329	329	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
974	330	330	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
975	331	331	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
976	CHEBI:83629	332	332	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
977	CHEBI:9715	26644-46-2	333	333	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
978	CHEBI:81972	88283-41-4	334	334	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
979	CHEBI:83823	847749-37-5	335	335	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
980	CHEBI:4998	60168-88-9	336	336	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
981	CHEBI:7645	63284-71-9	337	337	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
982	CHEBI:81927	35554-44-0	338	338	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
983	CHEBI:83832	134074-64-9	339	339	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
984	CHEBI:81775	101903-30-4	340	340	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
985	CHEBI:8434	67747-09-5	341	341	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
986	CHEBI:81784	68694-11-1	342	342	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
987	CHEBI:81898	60207-31-0	343	343	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
988	CHEBI:3130	55179-31-2	344	344	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
989	CHEBI:81900	116255-48-2	345	345	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
990	CHEBI:81758	94361-06-5	346	curative and systemic	346	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
991	CHEBI:81760	119446-68-3	347	347	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
992	CHEBI:81913	83657-18-5	348	348	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
993	CHEBI:4811	133855-98-8	349	349	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
994	CHEBI:4874	60207-93-4	350	350	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
995	CHEBI:81762	114369-43-6	351	351	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
996	CHEBI:83923	136426-54-5	352	352	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
997	CHEBI:81922	85509-19-9	353	353	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
998	CHEBI:81923	76674-21-0	354	354	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
999	CHEBI:81766	79983-71-4	355	355	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1000	CHEBI:81767	86598-92-7	356	356	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1001	CHEBI:81770	125225-28-7	357	357	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1002	CHEBI:81773	125116-23-6	358	358	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1003	CHEBI:75281	88671-89-0	359	359	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1004	CHEBI:81970	66246-88-6	360	360	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1005	CHEBI:8489	60207-90-1	361	361	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1006	CHEBI:81819	149508-90-7	362	362	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1007	CHEBI:81781	107534-96-3	363	363	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1008	CHEBI:81782	112281-77-3	364	364	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1009	CHEBI:9665	43121-43-3	365	365	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1010	CHEBI:9666	55219-65-3	366	366	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1011	CHEBI:81980	131983-72-7	367	367	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1012	CHEBI:82036	178928-70-6	368	368	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1013	CHEBI:83295	91315-15-0	369	systemic	369	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1014	CHEBI:81960	1593-77-7	370	systemic	370	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1015	CHEBI:50145	67564-91-4	371	systemic	371	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1016	CHEBI:9700	81412-43-3	372	systemic	372	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1017	CHEBI:81917	67306-00-7	373	systemic	373	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1018	CHEBI:83283	3478-94-2	374	374	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1019	CHEBI:9242	118134-30-8	375	systemic	375	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1020	CHEBI:81853	126833-17-8	376	locally systemic	376	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
1021	CHEBI:83327	473798-59-3	377	377	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
1022	CHEBI:81736	88678-67-5	378	systemic	378	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
1023	CHEBI:7451	65472-88-0	379	various	379	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
1024	CHEBI:9448	91161-71-6	380	various	380	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
1025	CHEBI:29703	37248-47-8	381	381	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
1026	CHEBI:26194	11113-80-7	382	382	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
1027	CHEBI:81848	110488-70-5	383	383	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1028	CHEBI:83428	211867-47-9	384	384	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1029	CHEBI:83663	868390-90-3	385	385	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1030	CHEBI:83601	413615-35-7	386	386	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1031	CHEBI:82023	140923-17-7	387	387	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1032	CHEBI:83610	283159-90-0	388	388	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1033	CHEBI:81802	374726-62-2	389	389	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1034	CHEBI:47617	27355-22-2	390	390	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
1035	CHEBI:45141	57369-32-1	391	391	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
1036	CHEBI:81783	41814-78-2	392	392	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
1037	CHEBI:3434	104030-54-8	393	393	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
1038	CHEBI:3434	139920-32-4	394	394	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
1039	CHEBI:3434	115852-48-7	395	395	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
1040	CHEBI:85628	911499-62-2	396	396	16.3	I	melanin synthesis in cell wall	I3	polyketide synthase in melanin biosythesis	MBI-P (Melanin Biosynthesis Inhibitors – Polyketide synthase)	trifluoroethyl-carbamate	tolprocarb	unknown	Resistance not known	
1041	CHEBI:3434	135158-54-2	397	397	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
1042	CHEBI:3434	27605-76-1	398	398	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
1043	CHEBI:81825	223580-51-6	399	399	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
1044	CHEBI:83657	224049-04-1	400	400	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
1045	CHEBI:6364	9008-22-4	401	401	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
1046	CHEBI:6364	402	402	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
1047	CHEBI:81788	57966-95-7	403	403	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
1048	CHEBI:84033	39148-24-8	404	404	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
1049	CHEBI:44976	13598-36-2	405	405	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
1050	CHEBI:83341	76280-91-6	406	406	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
1051	CHEBI:83335	72459-58-6	407	407	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
1052	CHEBI:81801	106917-52-6	408	408	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
1053	CHEBI:81759	62865-36-5	409	409	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
1054	CHEBI:81933	66952-49-6	410	410	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
1055	CHEBI:81797	180409-60-3	411	411	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
1056	CHEBI:83345	220899-03-6	412	412	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
1057	CHEBI:83346	688046-61-9	413	413	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
1058	CHEBI:74889	2439-10-3	414	414	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
1059	CHEBI:83277	958647-10-4	415	415	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
1060	CHEBI:81844	89269-64-7	416	416	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
1061	CHEBI:83268	1003318-67-9	417	417	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
1062	CHEBI:83266	376645-78-2	418	418	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
1063	CHEBI:85627	500207-04-5	419	419		U	unknown	U17	unknown	tetrazoyloxime	tetrazoyloxime	picarbutrazox	unknown	"Resistance not known.	
1064	420	420		Not cross resistant to PA, QoI, CAA"	U17								
1065	421	421	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
1066	7440-50-8	422	422	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1067	CHEBI:17909	7704-34-9	423	423	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1068	CHEBI:5015	14484-64-1	424	424	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1069	CHEBI:52492	8018-01-7	425	425	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1070	CHEBI:52497	12427-38-2	426	426	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1071	CHEBI:81539	9006-42-2	427	427	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1072	CHEBI:81755	12071-83-9	428	428	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1073	CHEBI:9495	137-26-8	429	429	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1074	CHEBI:52498	12122-67-7	430	430	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1075	CHEBI:79736	137-30-4	431	431	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1076	CHEBI:34608	133-06-2	432	432	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1077	CHEBI:81938	2425-06-1	433	433	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1078	CHEBI:82019	133-07-3	434	434	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1079	CHEBI:3639	1897-45-6	435	435	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1080	CHEBI:74875	1085-98-9	436	436	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1081	CHEBI:75182	731-27-1	437	437	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1082	CHEBI:82843	108173-90-6	438	438	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1083	CHEBI:5569	13516-27-3	439	439	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1084	CHEBI:82076	101-05-3	440	440	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1085	CHEBI:81842	3347-22-6	441	441	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1086	CHEBI:34620	2439-01-2	442	442	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1087	CHEBI:81826	41205-21-4	443	443	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1090	CHEBI:3009	71626-11-4	444	444	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1091	CHEBI:82779	98243-83-5	445	445	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1092	CHEBI:5194	57646-30-7	446	446	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1093	CHEBI:6790	57837-19-1	447	447	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1094	CHEBI:60607	70630-17-0	448	448	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1095	CHEBI:81937	77732-09-3	449	449	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1096	CHEBI:81969	58810-48-3	450	450	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1097	CHEBI:81952	41483-43-6	451	451	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
1098	CHEBI:81958	5221-53-4	452	452	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
1099	CHEBI:81989	23947-60-6	453	453	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
1100	CHEBI:5827	10004-44-1	454	454	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
1101	CHEBI:81936	26530-20-1	455	455	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
1102	CHEBI:138856	14698-29-4	456	456	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
1103	CHEBI:3015	17804-35-2	457	systemic	457	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1104	CHEBI:3392	10605-21-7	458	systemic	458	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1105	CHEBI:81926	3878-19-1	459	459	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1106	CHEBI:45979	148-79-8	460	460	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1107	CHEBI:82060	23564-06-9	461	461	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1108	CHEBI:35014	23564-05-8	462	systemic	462	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1109	CHEBI:4520	87130-20-9	463	systemic	463	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
1110	CHEBI:82048	156052-68-5	464	464	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
1111	CHEBI:82856	162650-77-3	465	465	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
1112	CHEBI:7957	66063-05-6	466	466	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
1113	CHEBI:81764	239110-15-7	467	467	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
1114	CHEBI:82860	130339-07-0	468	468	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
1115	CHEBI:38628	129558-76-5	469	469	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
1116	CHEBI:82052	15310-01-7	470	470	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1117	CHEBI:81792	66332-96-5	471	471	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1118	CHEBI:81823	55814-41-0	472	472	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1119	CHEBI:83065	875915-78-9	473	473	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1120	CHEBI:83070	658066-35-4	474	474	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1121	CHEBI:81994	24691-80-3	475	475	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1122	CHEBI:3405	5234-68-4	476	systemic	476	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1123	CHEBI:7858	5259-88-1	477	477	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1124	CHEBI:81794	130000-40-7	478	478	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1125	CHEBI:83092	1072957-71-1	479	479	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1126	CHEBI:83106	581809-46-3	480	480	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1127	CHEBI:83113	907204-31-3	481	481	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1128	CHEBI:81793	123572-88-3	482	482	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1129	CHEBI:83126	881685-58-1	483	483	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1130	CHEBI:83134	494793-67-8	484	484	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1131	CHEBI:81777	183675-82-3	485	485	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1132	CHEBI:83173	874967-67-6	486	486	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1133	CHEBI:81822	188425-85-6	487	487	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1134	CHEBI:40909	131860-33-8	488	preventive, curative, and systemic	488	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1135	CHEBI:83185	850881-70-8	489	489	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1136	CHEBI:83187	238410-11-2	490	490	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1137	CHEBI:83194	918162-02-4	491	491	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1138	CHEBI:83197	117428-22-5	492	492	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1139	CHEBI:83202	862588-11-2	493	493	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1140	CHEBI:83205	173662-97-0	494	494	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1141	CHEBI:78780	175013-18-0	495	495	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1142	CHEBI:83212	915410-70-7	496	496	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1143	CHEBI:83213	902760-40-1	497	497	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1144	CHEBI:2962	143390-89-0	498	498	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1145	CHEBI:81833	141517-21-7	499	499	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1146	CHEBI:83218	149961-52-4	500	500	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1147	CHEBI:83220	366815-39-6	501	501	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1148	CHEBI:81831	133408-50-1	502	502	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1149	CHEBI:81832	248593-16-0	503	503	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1150	CHEBI:59340	131807-57-3	504	504	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1151	CHEBI:83253	361377-29-9	505	505	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1152	CHEBI:83258	161326-34-7	506	506	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1153	CHEBI:83261	799247-52-2	507	507	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1154	CHEBI:81841	120116-88-3	508	508	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
1155	CHEBI:81846	348635-87-0	509	509	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
1156	CHEBI:82153	485-31-4	510	510	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
1157	CHEBI:83372	131-72-6	511	511	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
1158	CHEBI:83379	39300-45-3	512	512	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
1159	CHEBI:81843	79622-59-6	513	513	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
1160	CHEBI:81844	89269-64-7	514	514	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
1161	CHEBI:81918	900-95-8	515	515	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
1162	CHEBI:35036	639-58-7	516	516	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
1163	CHEBI:30473	76-87-9	517	517	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
1164	CHEBI:83393	175217-20-6	518	518	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
1165	CHEBI:83398	865318-97-4	519	519	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
1166	CHEBI:4045	121552-61-2	520	520	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
1167	CHEBI:6751	110235-47-7	521	521	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
1168	CHEBI:8674	53112-28-0	522	522	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
1169	CHEBI:15353	2079-00-7	523	523	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
1170	CHEBI:81419	6980-18-3	524	524	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
1171	CHEBI:17076	57-92-1	525	525	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
1172	CHEBI:27701	79-57-2	526	526	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
1173	CHEBI:82040	124495-18-7	527	527	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
1174	CHEBI:83555	189278-12-4	528	528	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
1175	CHEBI:34759	74738-17-3	529	529	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
1176	CHEBI:81763	131341-86-1	530	530	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
1177	CHEBI:3656	84332-86-5	531	531	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1178	CHEBI:28909	36734-19-7	532	preventive, early curative, and systemic	532	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1179	CHEBI:8450	32809-16-8	533	533	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1180	CHEBI:9986	50471-44-8	534	534	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1181	535	535	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
1182	CHEBI:34735	17109-49-8	536	536	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1183	CHEBI:79737	26087-47-8	537	537	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1184	CHEBI:81942	13457-18-6	538	538	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1185	CHEBI:6047	50512-35-1	539	539	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1186	CHEBI:17097	92-52-4	540	540	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1187	CHEBI:3628	2675-77-6	541	541	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1188	CHEBI:27864	99-30-9	542	542	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1189	CHEBI:34908	82-68-8	543	543	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1190	CHEBI:82044	117-18-0	544	544	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1191	CHEBI:81731	57018-04-9	545	545	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1192	CHEBI:81761	2593-15-9	546	546	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1193	CHEBI:83279	55406-53-6	547	547	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
1194	CHEBI:82033	24579-73-5	548	548	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
1195	CHEBI:82084	19622-08-3	549	549	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
1196	550	550	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
1197	551	551	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1198	552	552	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1199	553	553	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1200	554	554	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1201	CHEBI:83629	555	555	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
1202	CHEBI:9715	26644-46-2	556	556	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1203	CHEBI:81972	88283-41-4	557	557	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1204	CHEBI:83823	847749-37-5	558	558	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1205	CHEBI:4998	60168-88-9	559	559	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1206	CHEBI:7645	63284-71-9	560	560	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1207	CHEBI:81927	35554-44-0	561	561	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1208	CHEBI:83832	134074-64-9	562	562	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1209	CHEBI:81775	101903-30-4	563	563	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1210	CHEBI:8434	67747-09-5	564	564	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1211	CHEBI:81784	68694-11-1	565	565	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1212	CHEBI:81898	60207-31-0	566	566	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1213	CHEBI:3130	55179-31-2	567	567	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1214	CHEBI:81900	116255-48-2	568	568	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1215	CHEBI:81758	94361-06-5	569	curative and systemic	569	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1216	CHEBI:81760	119446-68-3	570	570	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1217	CHEBI:81913	83657-18-5	571	571	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1218	CHEBI:4811	133855-98-8	572	572	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1219	CHEBI:4874	60207-93-4	573	573	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1220	CHEBI:81762	114369-43-6	574	574	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1221	CHEBI:83923	136426-54-5	575	575	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1222	CHEBI:81922	85509-19-9	576	576	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1223	CHEBI:81923	76674-21-0	577	577	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1224	CHEBI:81766	79983-71-4	578	578	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1225	CHEBI:81767	86598-92-7	579	579	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1226	CHEBI:81770	125225-28-7	580	580	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1227	CHEBI:81773	125116-23-6	581	581	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1228	CHEBI:75281	88671-89-0	582	582	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1229	CHEBI:81970	66246-88-6	583	583	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1230	CHEBI:8489	60207-90-1	584	584	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1231	CHEBI:81819	149508-90-7	585	585	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1232	CHEBI:81781	107534-96-3	586	586	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1233	CHEBI:81782	112281-77-3	587	587	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1234	CHEBI:9665	43121-43-3	588	588	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1235	CHEBI:9666	55219-65-3	589	589	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1236	CHEBI:81980	131983-72-7	590	590	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1237	CHEBI:82036	178928-70-6	591	591	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1238	CHEBI:83295	91315-15-0	592	systemic	592	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1239	CHEBI:81960	1593-77-7	593	systemic	593	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1240	CHEBI:50145	67564-91-4	594	systemic	594	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1241	CHEBI:9700	81412-43-3	595	systemic	595	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1242	CHEBI:81917	67306-00-7	596	systemic	596	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1243	CHEBI:83283	3478-94-2	597	597	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1244	CHEBI:9242	118134-30-8	598	systemic	598	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1245	CHEBI:81853	126833-17-8	599	locally systemic	599	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
1246	CHEBI:83327	473798-59-3	600	600	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
1247	CHEBI:81736	88678-67-5	601	systemic	601	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
1248	CHEBI:7451	65472-88-0	602	various	602	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
1249	CHEBI:9448	91161-71-6	603	various	603	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
1250	CHEBI:29703	37248-47-8	604	604	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
1251	CHEBI:26194	11113-80-7	605	605	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
1252	CHEBI:81848	110488-70-5	606	606	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1253	CHEBI:83428	211867-47-9	607	607	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1254	CHEBI:83663	868390-90-3	608	608	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1255	CHEBI:83601	413615-35-7	609	609	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1256	CHEBI:82023	140923-17-7	610	610	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1257	CHEBI:83610	283159-90-0	611	611	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1258	CHEBI:81802	374726-62-2	612	612	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1259	CHEBI:47617	27355-22-2	613	613	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
1260	CHEBI:45141	57369-32-1	614	614	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
1261	CHEBI:81783	41814-78-2	615	615	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
1262	CHEBI:3434	104030-54-8	616	616	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
1263	CHEBI:3434	139920-32-4	617	617	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
1264	CHEBI:3434	115852-48-7	618	618	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
1265	CHEBI:85628	911499-62-2	619	619	16.3	I	melanin synthesis in cell wall	I3	polyketide synthase in melanin biosythesis	MBI-P (Melanin Biosynthesis Inhibitors – Polyketide synthase)	trifluoroethyl-carbamate	tolprocarb	unknown	Resistance not known	
1266	CHEBI:3434	135158-54-2	620	620	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
1267	CHEBI:3434	27605-76-1	621	621	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
1268	CHEBI:81825	223580-51-6	622	622	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
1269	CHEBI:83657	224049-04-1	623	623	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
1270	CHEBI:6364	9008-22-4	624	624	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
1271	CHEBI:6364	625	625	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
1272	CHEBI:81788	57966-95-7	626	626	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
1273	CHEBI:84033	39148-24-8	627	627	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
1274	CHEBI:44976	13598-36-2	628	628	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
1275	CHEBI:83341	76280-91-6	629	629	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
1276	CHEBI:83335	72459-58-6	630	630	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
1277	CHEBI:81801	106917-52-6	631	631	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
1278	CHEBI:81759	62865-36-5	632	632	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
1279	CHEBI:81933	66952-49-6	633	633	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
1280	CHEBI:81797	180409-60-3	634	634	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
1281	CHEBI:83345	220899-03-6	635	635	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
1282	CHEBI:83346	688046-61-9	636	636	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
1283	CHEBI:74889	2439-10-3	637	637	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
1284	CHEBI:83277	958647-10-4	638	638	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
1285	CHEBI:81844	89269-64-7	639	639	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
1286	CHEBI:83268	1003318-67-9	640	640	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
1287	CHEBI:83266	376645-78-2	641	641	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
1288	CHEBI:85627	500207-04-5	642	642	U17	U	unknown	U17	unknown	tetrazoyloxime	tetrazoyloxime	picarbutrazox	unknown	Resistance not known. Not cross resistant to PA, QoI, CAA	
1289	643	643	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
1290	7440-50-8	644	644	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1291	CHEBI:17909	7704-34-9	645	645	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1292	CHEBI:5015	14484-64-1	646	646	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1293	CHEBI:52492	8018-01-7	647	647	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1294	CHEBI:52497	12427-38-2	648	648	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1295	CHEBI:81539	9006-42-2	649	649	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1296	CHEBI:81755	12071-83-9	650	650	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1297	CHEBI:9495	137-26-8	651	651	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1298	CHEBI:52498	12122-67-7	652	652	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1299	CHEBI:79736	137-30-4	653	653	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1300	CHEBI:34608	133-06-2	654	654	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1301	CHEBI:81938	2425-06-1	655	655	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1302	CHEBI:82019	133-07-3	656	656	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1303	CHEBI:3639	1897-45-6	657	657	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1304	CHEBI:74875	1085-98-9	658	658	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1305	CHEBI:75182	731-27-1	659	659	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1306	CHEBI:82843	108173-90-6	660	660	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1307	CHEBI:5569	13516-27-3	661	661	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1308	CHEBI:82076	101-05-3	662	662	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1309	CHEBI:81842	3347-22-6	663	663	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1310	CHEBI:34620	2439-01-2	664	664	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1311	CHEBI:81826	41205-21-4	665	665	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
